Department of Health and Human Services June 22, 2010 – Federal Register Recent Federal Regulation Documents
Results 1 - 9 of 9
Guidance for Industry on Lupus Nephritis Caused By Systemic Lupus Erythematosus-Developing Medical Products for Treatment; Availability
The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled ``Lupus Nephritis Caused By Systemic Lupus ErythematosusDeveloping Medical Products for Treatment.'' This guidance provides recommendations for industry on developing human drugs, therapeutic biological products, and medical devices for the treatment of lupus nephritis (LN) caused by systemic lupus erythematosus (SLE). This guidance finalizes the parts of the draft guidance entitled ``Systemic Lupus ErythematosusDeveloping Drugs for Treatment'' (the draft guidance) regarding LN. Elsewhere in this issue of the Federal Register, FDA is announcing the availability of the guidance entitled ``Systemic Lupus ErythematosusDeveloping Medical Products for Treatment,'' which finalizes the draft guidance. Additional organ-specific guidances will be developed in the future.
Guidance for Industry on Systemic Lupus Erythematosus-Developing Medical Products for Treatment; Availability
The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled ``Systemic Lupus ErythematosusDeveloping Medical Products for Treatment.'' This guidance provides recommendations for industry on developing human drugs, therapeutic biological products, and medical devices for the treatment of systemic lupus erythematosus (SLE). This guidance finalizes the draft guidance entitled ``Systemic Lupus Erythematosus Developing Drugs for Treatment'' (the draft guidance). Elsewhere in this issue of the Federal Register, FDA is announcing the availability of the guidance entitled ``Lupus Nephritis Caused by Systemic Lupus ErythematosusDeveloping Medical Products for Treatment,'' which finalizes the parts of the draft guidance regarding lupus nephritis.
Updated Guidance: Prevention Strategies for Seasonal Influenza in Healthcare Settings
The Centers for Disease Control and Prevention (CDC), located in the Department of Health and Human Services (HHS), seeks public comment on proposed new guidance which will update and replace previous seasonal influenza guidance and the Interim Guidance on Infection Control Measures for 2009 H1N1 Influenza in Healthcare Settings.
Funding Opportunity; Street Outreach Program
This announcement governs the proposed award of discretionary grants under the Street Outreach Program. It sets forth the application requirements, the application process, and other administrative and fiscal requirements for grants in Fiscal Year (FY) 2010. The purpose of the Street Outreach Program is to conduct outreach services designed to build relationships between grantee staff and runaway, homeless and street youth.
Funding Opportunity; Basic Center Program
The Family and Youth Services Bureau (FYSB) is accepting applications for the Basic Center Program (BCP), which is
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
